Dipeptidyl peptidase-4 inhibitors-associated bullous pemphigoid: A retrospective study of 168 pemphigoid and 9,304 diabetes mellitus patients-Reference-Cited by-同舟云学术

Dipeptidyl peptidase-4 inhibitors-associated bullous pemphigoid: A retrospective study of 168 pemphigoid and 9,304 diabetes mellitus patients

Published:2018-07-25 Issue:2 Volume:10 Page:392-398
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Investig

Author:

Kawaguchi Yohei¹^ORCID,Shimauchi Risa¹,Nishibori Nobuhiro¹,Kawashima Kiyohito¹,Oshitani So¹,Fujiya Atsushi¹^ORCID,Shibata Taiga¹,Ohashi Norimi¹,Izumi Kentaro²,Nishie Wataru²,Shimizu Hiroshi²,Arima Hiroshi³,Sobajima Hiroshi¹

Affiliation:

1. Department of Diabetology and Nephrology; Ogaki Municipal Hospital; Ogaki Japan

2. Department of Dermatology; Hokkaido University Graduate School of Medicine; Sapporo Japan

3. Department of Endocrinology and Diabetes; Nagoya University Graduate School of Medicine; Nagoya Japan

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdi.12877/fullpdf

Reference25 articles.

1. Bullous pemphigoid: etiology, pathogenesis, and inducing factors: facts and controversies;Lo Schiavo;Clin Dermatol,2013

2. Drug-induced pemphigoid: bullous and cicatricial;Vassileva;Clin Dermatol,1998

3. Drug-induced pemphigoid: a review of the literature;Stavropoulos;J Eur Acad Dermatol Venereol,2014

4. Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid;Yoshida;J Dermatol Sci,2006

5. Autoantibody profile differentiates between inflammatory and noninflammatory bullous pemphigoid;Izumi;J Invest Dermatol,2016

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Risk Factors for Gliptin-associated Bullous Pemphigoid among Diabetic Patients;Acta Dermato-Venereologica;2024-04-04

2. The negative impact of medications on wound healing;Wound Practice and Research;2024-03

3. Exploring the clinical utility of DPP-IV and SGLT2 inhibitors in papillary thyroid cancer: a literature review;Frontiers in Pharmacology;2024-01-16

4. From Molecular Insights to Clinical Perspectives in Drug-Associated Bullous Pemphigoid;International Journal of Molecular Sciences;2023-11-26

5. Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid with oral mucosal lesions: A case report;Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology;2023-11